We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Partnership to Develop Cardiac PET

By MedImaging staff writers
Posted on 26 Jan 2006
Imagin Molecular Corp. More...
(IMGM, Oakbrook, IL, USA) has entered into an agreement with PET Management Services (PMS, Niagara, NY, USA) to pursue molecular imaging partnerships.

PET Management Services is a developer of molecular imaging systems that bring to IMGM, formerly known as Cipher Multimedia, Inc., the necessary bioinformatics research and imaging center management that validates the usefulness of positron emission tomography (PET) as a primary coronary diagnostic tool.

PMS enables Imagin Nuclear Partners (INP), Imagin Molecular's subsidiary, to provide dedicated evidence-based medical systems for cardiac disease diagnostics and treatments driven by bioinformatics. PMS has data that demonstrate cost-savings to insurance companies when cardiac PET is performed on selected patients as a first-line modality rather than single photon computed tomography (SPECT) scans.

PMS will partner with INP and will operate joint ventures with PET imaging centers. INP is a full-service joint venture molecular imaging partner that will own, operate, and administer out-patient medical diagnostic imaging centers that utilizes PET and PET/CT scanning equipment.

Joe Oliverio, president of PET Management Services stated, "We have one of the most robust cardiac PET patient databases and are preparing to publish manuscripts that will revolutionize the way coronary disease detection and management is performed for decades to come.”




Related Links:
Imagin Molecular

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.